CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Defensive Interval Ratio

Latest as of June 2025: 24 days

CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Defensive Interval Ratio of 24 days as of June 2025. Defensive assets of $500.00K (cash $-, short-term investments $500.00K, receivables $-) cover 24 days of daily cash needs of $20.87K/day.

Defensive Interval Ratio

24 days
Days of operational coverage

Defensive Assets

$500.00K
Cash + ST Investments + Receivables

Daily Cash Need

$20.87K
Current Liabilities ÷ 365

Current Liabilities

$7.62 Million
USD

CERo Therapeutics Holdings, Inc. Common Stock Defensive Interval Ratio (2023–2023)

This chart shows how CERo Therapeutics Holdings, Inc. Common Stock's Defensive Interval Ratio has evolved across 1 annual periods from 2023 to 2023. As of June 2025, the ratio stands at 24 days, meaning defensive assets of $500.00K can fund 24 days of operations without new revenue. For the complete balance sheet picture, see CERo Therapeutics Holdings, Inc. Common (CERO) total assets.

Annual Defensive Interval Ratio for CERo Therapeutics Holdings, Inc. Common Stock (2023–2023)

The table below presents the year-by-year Defensive Interval Ratio for CERo Therapeutics Holdings, Inc. Common Stock from 2023 to 2023, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See CERo Therapeutics Holdings, Inc. Common current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2023 595 days $8.44 Million $14.17K/day $- $8.44 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)